{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2781,"total_is_capped":false,"direct_labels_cover":13,"predictions_cover":2781,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"2971a1dca752","filters":{"topic":"Breast Cancer Treatment Studies"}},"results":[{"id":"W2170602872","doi":"10.1158/1078-0432.ccr-06-3045","title":"Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5106,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Triple-negative breast cancer; Hazard ratio; Internal medicine; Oncology; Confidence interval; Cancer; Cohort; Proportional hazards model; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.1312351163977038,"gpt":0.5259002702839296,"spread":0.3946651538862258,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00340718,0.0001893721,0.0004561743,0.00007383918,0.0001435283,0.00001813836,0.0003255671,0.0002941618,0.00008401339],"category_scores_gemma":[0.0009079716,0.0001546357,0.0001793383,0.0002334754,0.00111542,0.000006965329,0.0004451926,0.0006436908,0.000003856055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005438718,"about_ca_system_score_gemma":0.0003749116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002649976,"about_ca_topic_score_gemma":0.004660538,"domain_scores_codex":[0.9970372,0.000466941,0.0007465251,0.000757386,0.0004413847,0.0005505235],"domain_scores_gemma":[0.9975478,0.0009073639,0.0001859005,0.0004354516,0.0006461379,0.0002773291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002151294,0.0002461917,0.8175543,0.00004961474,0.0002455958,0.000007755688,0.00006920548,6.366585e-7,0.0003372695,0.00005000526,0.006757478,0.1725307],"study_design_scores_gemma":[0.002098141,0.000470621,0.9881704,0.0001391778,0.00003568972,0.00001146774,0.0002226477,0.000001428201,0.004686452,0.0001180468,0.003882282,0.0001636247],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98881,0.006998175,0.00006157717,0.002009142,0.0006565486,0.0004022981,0.0006063332,0.00001027779,0.0004456286],"genre_scores_gemma":[0.9696975,0.02799249,0.0001352123,0.0002332888,0.001359867,0.00008758769,0.00001914255,0.00002400919,0.0004509198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1723671,"threshold_uncertainty_score":0.6305859,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137853125","doi":"10.1200/jco.2009.25.6529","title":"American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4267,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Estrogen receptor; Guideline; Internal medicine; Progesterone receptor; Cancer; Estrogen; Immunohistochemistry; Gynecology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1044654445549377,"gpt":0.4879802130540102,"spread":0.3835147684990725,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003404209,0.000184827,0.001981257,0.00005972757,0.00003174711,0.000001353389,0.0002638749,0.0003754073,0.000009760822],"category_scores_gemma":[0.003274448,0.0001491973,0.0005175357,0.0002101201,0.002376887,0.00001011549,0.0001802194,0.0006090896,1.018794e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006722041,"about_ca_system_score_gemma":0.001653236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003387775,"about_ca_topic_score_gemma":0.000293365,"domain_scores_codex":[0.9948829,0.0003748163,0.004033532,0.0003194029,0.0001501738,0.0002391976],"domain_scores_gemma":[0.9909925,0.001822445,0.005764322,0.0002358866,0.001031689,0.0001531469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002997467,0.001986729,0.5841122,0.00003286534,0.0005308464,0.000003371688,0.00006186512,0.000006380851,0.0378149,0.00001458303,0.006420092,0.3660187],"study_design_scores_gemma":[0.01500235,0.02497526,0.8488719,0.0001914225,0.0007313594,0.0003361797,0.001651339,0.0001300779,0.009862926,0.0001758643,0.09766392,0.000407377],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860396,0.0003227259,0.0001182662,0.01221965,0.0006677001,0.0002547828,0.0003315038,0.000002775295,0.00004293683],"genre_scores_gemma":[0.8464482,0.001439453,0.1508996,0.0004939849,0.0006377188,0.00003171208,0.00001940491,0.00001912041,0.00001078425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3656113,"threshold_uncertainty_score":0.8757738,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096027508","doi":"10.1056/nejmra1001389","title":"Triple-Negative Breast Cancer","year":2010,"lang":"en","type":"review","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4170,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Progesterone receptor; Estrogen receptor; Triple-negative breast cancer; Cancer; Oncology; Triple negative; Estrogen; Internal medicine; Cancer research; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.02465585975998503,"gpt":0.341892438205226,"spread":0.3172365784452409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003224583,0.0003656789,0.001430692,0.0001253274,0.00004809043,0.00000679148,0.0002744992,0.0002593926,0.0001835507],"category_scores_gemma":[0.0002049685,0.0002046494,0.0002931194,0.0001259989,0.0001575819,0.0000033649,0.00005507713,0.0005511771,0.000003755722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005262827,"about_ca_system_score_gemma":0.0007037877,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001691905,"about_ca_topic_score_gemma":0.0001909918,"domain_scores_codex":[0.9985712,0.0001146742,0.0006178369,0.0002179395,0.0002739032,0.0002045009],"domain_scores_gemma":[0.9983652,0.00009037209,0.000860062,0.0002273894,0.0002361963,0.0002207653],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001510281,0.00002480208,0.00004546866,0.0003902939,0.000682962,0.0000363549,0.00007656248,2.367374e-7,0.00002411134,0.000004760144,0.01829785,0.9802656],"study_design_scores_gemma":[0.01181571,0.0002915476,0.0001339896,0.005405321,0.001599577,0.00309129,0.00001883249,4.029314e-8,0.00001599974,0.00003705717,0.9774172,0.0001734441],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000041052,0.9959313,0.00003368334,0.00144298,0.0018867,0.0001631605,0.0000877709,0.00000307046,0.0004102559],"genre_scores_gemma":[0.0001243226,0.9768658,0.000133516,0.0001347202,0.02198798,0.000009550258,0.00003607115,0.00003892728,0.0006690777],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9800921,"threshold_uncertainty_score":0.8345362,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161426850","doi":"10.1001/jama.295.21.2492","title":"Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study","year":2006,"lang":"en","type":"article","venue":"JAMA","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3834,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Estrogen receptor; Internal medicine; Population; Cancer; Progesterone receptor; Odds ratio; Cytokeratin; Immunohistochemistry; Gynecology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.006826089804423186,"gpt":0.2567075135224621,"spread":0.2498814237180389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001580566,0.0001851064,0.0001823211,0.00002875421,0.0001048554,0.00003557916,0.0001495332,0.00007824316,0.00002626327],"category_scores_gemma":[0.000004756849,0.0001284086,0.00003896277,0.0001315252,0.00008240276,0.000006244639,0.00009619387,0.00009753263,0.000002397273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004598363,"about_ca_system_score_gemma":0.00006555131,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02392579,"about_ca_topic_score_gemma":0.0423758,"domain_scores_codex":[0.9989799,0.0001017913,0.0001495012,0.0003549754,0.0001583724,0.000255493],"domain_scores_gemma":[0.9995601,0.0000188227,0.000055727,0.0002599263,0.00007632928,0.00002914546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002443969,0.0002756079,0.9868457,0.00001003143,0.00009059766,0.00001404922,0.0002447939,0.00003229915,0.0008600647,0.0000283757,0.003374154,0.007979955],"study_design_scores_gemma":[0.00201165,0.00003868302,0.9940814,0.00001275374,0.000055586,0.00006027421,0.0004992196,0.000004642121,0.000199494,0.00002064812,0.002863605,0.0001520113],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895927,0.003439746,0.000001993605,0.005348654,0.0001604449,0.000281419,0.0004105583,0.000009318663,0.0007552187],"genre_scores_gemma":[0.9978264,0.0005247628,0.000006987962,0.0002864486,0.0008655239,0.0002180093,0.00002953311,0.00001904448,0.000223287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01845001,"threshold_uncertainty_score":0.982574,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117775530","doi":"10.1093/annonc/mdt303","title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3715,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Trastuzumab; Oncology; Cancer; Disease; Radiation therapy; Internal medicine; Surrogate endpoint; Systemic therapy; Bioinformatics","retraction":null,"screen_n_in":null,"score":{"opus":0.03251626647592759,"gpt":0.3067521116577411,"spread":0.2742358451818135,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001085675,0.0002033192,0.0003774569,0.00003109945,0.00007605586,0.000005401578,0.0003518226,0.00009191303,0.0001696859],"category_scores_gemma":[0.000004231352,0.00008911203,0.0001349929,0.00008050023,0.0006789442,0.000006048098,0.00006507713,0.00005534784,9.209462e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001226627,"about_ca_system_score_gemma":0.0003146166,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01373676,"about_ca_topic_score_gemma":0.0006163261,"domain_scores_codex":[0.9988262,0.0001549796,0.0002943867,0.0002333686,0.0002387244,0.0002523496],"domain_scores_gemma":[0.9984884,0.0001219139,0.0004669801,0.0003719665,0.0005109011,0.00003980901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02329607,0.007483691,0.3024153,0.0001014651,0.02041421,0.000008964051,0.04229704,0.0002504606,0.3145598,0.00114572,0.04980822,0.238219],"study_design_scores_gemma":[0.002227714,0.003315099,0.9181902,0.0000901727,0.00004246868,0.00002704037,0.001136058,0.000002860806,0.05177297,0.00004353296,0.02300928,0.0001425365],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9471393,0.003381263,5.185933e-7,0.04784627,0.0001354258,0.0004289789,0.0004982374,0.000002891076,0.0005671293],"genre_scores_gemma":[0.9823213,0.01618888,0.00001901905,0.0007502711,0.0001591302,0.0003989689,0.000006799965,0.00001764025,0.0001380128],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6157749,"threshold_uncertainty_score":0.9928309,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805734855","doi":"10.1056/nejmoa1804710","title":"Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2369,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Sunnybrook Hospital","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; ECOG-ACRIN Cancer Research Group; Breast Cancer Research Foundation; Johns Hopkins University; American College of Radiology Imaging Network; Susan G. Komen for the Cure","keywords":"Adjuvant; Breast cancer; Adjuvant chemotherapy; Oncology; Medicine; Cancer; Chemotherapy; Gene expression; Gene; Cancer research; Internal medicine; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01030452404452895,"gpt":0.287832908951248,"spread":0.2775283849067191,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003498179,0.00014454,0.0002856716,0.00005665057,0.00003385515,0.000003811618,0.0001318147,0.00006844453,0.0001806789],"category_scores_gemma":[0.00005038233,0.00009075757,0.00004094689,0.00008234783,0.0001106718,0.000005008496,0.00002708416,0.00009610444,0.000001225666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004336777,"about_ca_system_score_gemma":0.0001056902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002959735,"about_ca_topic_score_gemma":0.0001079434,"domain_scores_codex":[0.9990831,0.00006270401,0.0003133284,0.0001532569,0.0002134435,0.0001741952],"domain_scores_gemma":[0.9993497,0.00001904857,0.0002031632,0.0001381019,0.0001651574,0.000124844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001107057,0.00006420966,0.0357817,0.000005450036,0.00009599981,0.00001612782,0.000424885,0.000003564681,0.7103925,7.776268e-7,0.1813903,0.07071736],"study_design_scores_gemma":[0.08237414,0.001275839,0.08904786,0.0006672022,0.00009965998,0.001224125,0.0001795474,0.000007932677,0.6265554,0.0001240526,0.198162,0.0002821997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9622666,0.01080302,0.0007680068,0.02490593,0.0006751125,0.0000932294,0.00002637419,0.000004657976,0.0004571014],"genre_scores_gemma":[0.9881707,0.00356111,0.000373317,0.001232957,0.006361753,0.000003236521,0.00001292397,0.00001708538,0.000266908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08383708,"threshold_uncertainty_score":0.3700986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116760308","doi":"10.1200/jco.2009.25.9820","title":"Metastatic Behavior of Breast Cancer Subtypes","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2284,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Basal (medicine); Internal medicine; Oncology; Cancer; Pathology; Lung cancer; Lung; Metastasis; Stage (stratigraphy); Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06226160108180336,"gpt":0.4550223279959653,"spread":0.392760726914162,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008049377,0.000102471,0.0006628333,0.00003706179,0.00002301913,0.000002771382,0.0001905643,0.0001871847,0.0001439977],"category_scores_gemma":[0.00049668,0.00007188594,0.0003271255,0.00005083711,0.0002845451,0.000004941282,0.00006601686,0.0003434005,0.000003126009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001365655,"about_ca_system_score_gemma":0.0007401727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006575212,"about_ca_topic_score_gemma":0.0004755559,"domain_scores_codex":[0.9984061,0.0001274716,0.001047913,0.0001346527,0.0001468111,0.0001370424],"domain_scores_gemma":[0.9979088,0.0002080752,0.001143128,0.000164125,0.0004503489,0.0001254862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002117136,0.002232484,0.7144217,0.00001829679,0.001062379,0.00008013102,0.00004218363,0.000008630956,0.08105303,0.0001079651,0.004149503,0.1947066],"study_design_scores_gemma":[0.002728862,0.001583104,0.9594917,0.00001270215,0.0005453246,0.0003871208,0.00004899048,0.000001246863,0.007180354,0.00007966954,0.02785136,0.00008958641],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954417,0.0005512856,0.00002931031,0.001856526,0.001636774,0.00006286184,0.00004472859,0.000001607164,0.0003752309],"genre_scores_gemma":[0.9955738,0.0006812164,0.002315563,0.0003296765,0.001000162,0.000008648593,0.000002730305,0.00001126041,0.00007700182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.24507,"threshold_uncertainty_score":0.2931423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127057139","doi":"10.1093/jnci/djp082","title":"Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer","year":2009,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2220,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Cancer Institute","keywords":"Breast cancer; Immunohistochemistry; Medicine; Estrogen receptor; Tissue microarray; Oncology; Internal medicine; Proliferation index; Proliferative index; Cancer; Hormone receptor; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01019273323395022,"gpt":0.2711020322188619,"spread":0.2609092989849117,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006726439,0.0001173208,0.0001536207,0.00004520088,0.00008331754,0.0000107624,0.000131678,0.00004511628,0.000009356076],"category_scores_gemma":[0.00002314832,0.00007151154,0.000062197,0.0001176378,0.0001520284,0.00002378438,0.0000386119,0.00008921976,9.187487e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001314735,"about_ca_system_score_gemma":0.0004664238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001354789,"about_ca_topic_score_gemma":0.000298314,"domain_scores_codex":[0.9990661,0.00001882744,0.0002177683,0.0001182662,0.0004507896,0.0001282646],"domain_scores_gemma":[0.9987054,0.000005658366,0.0003542918,0.00005985084,0.0008208835,0.00005386455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009394152,0.0001870417,0.9875274,0.00001639882,0.0003441468,6.490762e-7,0.00007459214,0.0007341991,0.0008698722,0.00005143274,0.001835675,0.007419216],"study_design_scores_gemma":[0.001564623,0.0001470158,0.9888424,0.00009925597,0.00008190515,0.0000192738,0.00001145956,0.000002333015,0.002843486,0.0000691348,0.00623383,0.00008530634],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959449,0.001186907,0.00001467314,0.001931066,0.0003712343,0.0001138316,0.0003216057,0.000001478835,0.0001142925],"genre_scores_gemma":[0.9983467,0.0004779788,0.0001285443,0.0004608791,0.0005280167,0.0000105113,0.0000078782,0.000006431632,0.00003302696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00733391,"threshold_uncertainty_score":0.2916156,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131719808","doi":"10.1016/s1470-2045(10)70207-2","title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","year":2010,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1919,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint John Regional Hospital; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Axillary Lymph Node Dissection; Sentinel lymph node; Breast cancer; Lumpectomy; Mastectomy; Surgery; Axilla; Sentinel node; Lymph node; Clinical endpoint; Randomized controlled trial; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02129551545244373,"gpt":0.3209903072835433,"spread":0.2996947918310996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006140416,0.0003188209,0.0006439848,0.00003443286,0.0003090357,0.00003956344,0.0003393223,0.0002257026,0.0001000689],"category_scores_gemma":[0.0001431263,0.0001793361,0.0001233068,0.0001582262,0.0004943406,0.0000174865,0.0001238654,0.0003677511,0.000005683277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001659343,"about_ca_system_score_gemma":0.0003132531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001839465,"about_ca_topic_score_gemma":0.003829614,"domain_scores_codex":[0.9976698,0.0005652051,0.0004655413,0.0005700163,0.0003010724,0.0004283191],"domain_scores_gemma":[0.9983297,0.0005012383,0.0003831463,0.0004668921,0.0002497312,0.00006928152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4295141,0.0009080696,0.5647764,0.000008496728,0.0006281505,0.000006238852,0.0002440585,0.0001420968,0.002608995,0.00002459567,0.0005783524,0.000560439],"study_design_scores_gemma":[0.3148481,0.0003454618,0.6830004,0.00003743047,0.0001631387,0.00001799879,0.0001134973,0.00009738152,0.0004026331,0.00006505499,0.0007000137,0.0002088513],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931682,0.00005636858,0.0001283484,0.003833825,0.0009757088,0.0008695625,0.0005353298,0.00002647446,0.0004061264],"genre_scores_gemma":[0.9963081,0.0001311619,0.0001786979,0.0007440012,0.001517263,0.000445577,0.0005900569,0.0000353057,0.0000498328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1182241,"threshold_uncertainty_score":0.7313116,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103608035","doi":"10.1056/nejmoa0906260","title":"Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1867,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal General Hospital; McGill University; Windsor Regional Hospital; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Northeast Cancer Centre; Thunder Bay Regional Health Sciences Centre; Ottawa Regional Cancer Foundation; McMaster University","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Regimen; Confidence interval; Dose fractionation; Breast-conserving surgery; Axillary lymph nodes; Randomized controlled trial; Surgery; Nuclear medicine; Mastectomy; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01182513699213316,"gpt":0.2988430602458249,"spread":0.2870179232536917,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002266412,0.0000811594,0.000172826,0.00004670806,0.00002702133,0.00000201773,0.00007006752,0.00005542994,0.00003722015],"category_scores_gemma":[0.0001099163,0.00005185364,0.00004880878,0.00004357717,0.00005570865,0.000005886467,0.000006392795,0.00008439452,1.354874e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001047271,"about_ca_system_score_gemma":0.0001119831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001320695,"about_ca_topic_score_gemma":0.0001401955,"domain_scores_codex":[0.9994293,0.00001760924,0.0002612362,0.00008473104,0.0001261893,0.00008092479],"domain_scores_gemma":[0.9991843,0.00005063686,0.0003260104,0.00009151194,0.0002832279,0.00006430294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006066845,0.00007194065,0.04074715,0.00001001827,0.0003097565,0.000002913852,0.0001569595,0.00001731834,0.3053353,0.000007977496,0.006702719,0.6405712],"study_design_scores_gemma":[0.06901099,0.0008870022,0.8449748,0.00006442163,0.00009611493,0.0003435571,0.00001947047,0.000003474924,0.05376004,0.00006448669,0.03069795,0.00007766988],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859009,0.002719769,0.000248318,0.009920804,0.0009654645,0.00009940461,0.00007259832,0.00000198208,0.0000707459],"genre_scores_gemma":[0.9909979,0.003214399,0.0001300968,0.0001779665,0.005331778,0.000003166662,0.00003489811,0.000008617276,0.0001011879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8042277,"threshold_uncertainty_score":0.211453,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2767600184","doi":"10.1056/nejmoa1701830","title":"20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years","year":2017,"lang":"en","type":"review","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1810,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging; Medical Research Council; Rijksuniversiteit Groningen; University of Oxford; Massachusetts Medical Society; National Institute for Health and Care Research; British Heart Foundation; Cancer Research UK","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Proportional hazards model; Cancer; Endocrine system; Stage (stratigraphy); Disease; Gynecology; Hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.1155099890975973,"gpt":0.416234974307602,"spread":0.3007249852100047,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003144864,0.0003174481,0.001385,0.0001143539,0.0000442894,0.000006457833,0.0003527807,0.0001305306,0.0002114523],"category_scores_gemma":[0.00008553301,0.0001971618,0.0003059165,0.00005844537,0.0001911455,0.000005569624,0.0001110516,0.0002665238,0.000002855423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006306737,"about_ca_system_score_gemma":0.0003161634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001320409,"about_ca_topic_score_gemma":0.00006016885,"domain_scores_codex":[0.9985057,0.0001161706,0.0006200042,0.0002364949,0.0003090581,0.0002125972],"domain_scores_gemma":[0.9979844,0.00005402685,0.001237291,0.0003894622,0.0001911283,0.000143678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005508676,0.00002957666,0.001375033,0.0004867625,0.0007796129,0.00006247884,0.00007937077,6.805958e-7,0.00004264976,9.134938e-7,0.004711706,0.9918804],"study_design_scores_gemma":[0.009095345,0.0003996165,0.004017455,0.009640384,0.0006603875,0.001240852,0.000009762603,4.382514e-8,0.00002670445,0.000009921913,0.9747353,0.0001642961],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001996115,0.9961994,0.000009064546,0.0005165361,0.0008394195,0.0001595693,0.0001179242,0.000001949665,0.0001600262],"genre_scores_gemma":[0.005065683,0.9883682,0.00006923897,0.00004799931,0.005986821,0.00001271405,0.00003051916,0.00003299195,0.0003858963],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.991716,"threshold_uncertainty_score":0.8040023,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2999400187","doi":"10.1200/jco.19.02309","title":"Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1497,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"National Cancer Institute","keywords":"Medicine; Guideline; Breast cancer; Oncology; Estrogen receptor; Cancer; Internal medicine; Progesterone receptor; Gynecology; Estrogen; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.08838685065811515,"gpt":0.424895718177958,"spread":0.3365088675198428,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007484445,0.00013679,0.0006666452,0.0000205725,0.00003041169,0.000007699227,0.0001509961,0.0002074767,0.00002171568],"category_scores_gemma":[0.001011927,0.0001066961,0.0001110917,0.00009308114,0.0001528063,0.000008382361,0.0001478714,0.000304389,0.000003791618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003894541,"about_ca_system_score_gemma":0.0005839948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005945677,"about_ca_topic_score_gemma":0.00005494126,"domain_scores_codex":[0.997887,0.0001828638,0.001375107,0.0002435396,0.0001198045,0.0001917482],"domain_scores_gemma":[0.9984148,0.000151353,0.0008410718,0.00009164598,0.0002725584,0.0002285696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002569498,0.000407617,0.7424225,0.0000206614,0.0003769075,0.0000835914,0.00005086324,0.00006736319,0.006757555,0.00001703791,0.01240984,0.2348166],"study_design_scores_gemma":[0.01196293,0.006053233,0.6379083,0.0001215079,0.0002679247,0.0005757645,0.0001996964,0.0001428008,0.001733061,0.00007450331,0.3406136,0.0003466098],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9327103,0.003896453,0.00005417067,0.06276616,0.0003017403,0.0001013348,0.00004126659,0.000004525554,0.0001240375],"genre_scores_gemma":[0.9762698,0.003542361,0.01169984,0.006106428,0.002331645,0.000009400525,0.00001036604,0.00002044489,0.000009691522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3282038,"threshold_uncertainty_score":0.4350942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2190954851","doi":"10.1056/nejmoa1510764","title":"Prospective Validation of a 21-Gene Expression Assay in Breast Cancer","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1439,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Hospital; Juravinski Cancer Centre","funders":"Yonsei University College of Medicine; University of North Carolina at Chapel Hill; Sunnybrook Research Institute; Yonsei University; National Institutes of Health; ECOG-ACRIN Cancer Research Group; School of Medicine, Virginia Commonwealth University; Vanderbilt University; Virginia Commonwealth University; Northwestern University; National Cancer Institute; Emory University; University of Pittsburgh; School of Medicine, Indiana University; Johns Hopkins University; Wake Forest University; American College of Radiology Imaging Network","keywords":"Biomarker; Breast cancer; Oncology; Prospective cohort study; Medicine; Internal medicine; Cancer; Gene expression; Gene; Bioinformatics; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01586878993622166,"gpt":0.2877386254713162,"spread":0.2718698355350945,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004005816,0.00008244867,0.0002126582,0.00006118767,0.000009978731,0.000001559488,0.00006643537,0.00004203663,0.00001702568],"category_scores_gemma":[0.0001191648,0.00005256594,0.00002614487,0.00007736793,0.00004678444,0.000005608833,0.00002318095,0.00006958842,2.363575e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004893587,"about_ca_system_score_gemma":0.0001610851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002370164,"about_ca_topic_score_gemma":0.00005163816,"domain_scores_codex":[0.9993107,0.00006280849,0.000245062,0.0000899267,0.0002081909,0.00008336349],"domain_scores_gemma":[0.9993362,0.00001704399,0.0002260282,0.00008025535,0.000250695,0.00008976327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002581605,0.000118118,0.5342751,0.00001505264,0.0001286005,0.00002100433,0.00166699,0.0002741761,0.4350856,0.000006650494,0.00720501,0.01862218],"study_design_scores_gemma":[0.05595822,0.0009324162,0.2488475,0.0005201958,0.0001123505,0.0005030815,0.0005374124,0.000004253601,0.6888989,0.0004402288,0.003117332,0.0001281591],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923704,0.003054386,0.0003984993,0.003492623,0.0003084315,0.00007075817,0.00001006941,0.000001438987,0.0002933688],"genre_scores_gemma":[0.9972795,0.0004594043,0.000311784,0.00005345143,0.001824293,0.000002885469,0.000007744225,0.000006849834,0.00005413846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2854276,"threshold_uncertainty_score":0.2143577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113344831","doi":"10.1016/s1470-2045(09)70314-6","title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1405,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Genomic Health; U.S. Department of Health and Human Services","keywords":"Tamoxifen; Medicine; Internal medicine; Breast cancer; Oncology; Hazard ratio; Proportional hazards model; Anthracycline; Chemotherapy; Cyclophosphamide; Retrospective cohort study; Gynecology; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.008274236675616017,"gpt":0.2673977770089922,"spread":0.2591235403333762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004154271,0.0002294412,0.0007942038,0.00007197369,0.00007383073,0.000005839523,0.0002246133,0.0001194587,0.000009391318],"category_scores_gemma":[0.00007666785,0.0001293638,0.00008102765,0.0004984828,0.0004415424,0.00000542608,0.00006096897,0.0001652507,1.591883e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002630986,"about_ca_system_score_gemma":0.0002112067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001145933,"about_ca_topic_score_gemma":0.0001473169,"domain_scores_codex":[0.9983449,0.0004955434,0.0002621734,0.0004030182,0.0001855396,0.0003088343],"domain_scores_gemma":[0.9989283,0.0001747312,0.0003585888,0.0003236714,0.000174436,0.00004028887],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6287138,0.001449358,0.2855937,0.00001830492,0.007420266,0.000005826934,0.005118176,0.001012942,0.06529313,0.0002019041,0.00007002119,0.005102526],"study_design_scores_gemma":[0.05639826,0.00485297,0.9221349,0.00007077165,0.000714069,0.00001118858,0.000187184,0.00006902451,0.01535723,0.00006433223,0.000007987542,0.0001320592],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951506,0.0003544432,0.00004826474,0.001952397,0.00006342032,0.001200244,0.0009142787,0.000005245936,0.0003111639],"genre_scores_gemma":[0.9984028,0.0003634302,0.00009396353,0.0005853605,0.0001600455,0.0003285193,0.00004672119,0.00001202919,0.000007156657],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6365412,"threshold_uncertainty_score":0.5275304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986993149","doi":"10.1056/nejmoa020128","title":"Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation","year":2002,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1386,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"SUNY Downstate Medical Center; University of California, San Diego; University of Illinois at Urbana-Champaign; Jewish General Hospital; Temple University; National Cancer Institute; University of Rochester; Creighton University; Louisiana State University; University of Pittsburgh; University of Pennsylvania; Wayne State University","keywords":"Medicine; Mastectomy; Radical mastectomy; Randomized controlled trial; Radiation therapy; Total Mastectomy; Breast cancer; Surgery; Modified Radical Mastectomy; General surgery; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01231835373684233,"gpt":0.2394237526944975,"spread":0.2271053989576551,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007742103,0.0002796004,0.001223595,0.0001475824,0.00006944567,0.00001461754,0.0001312318,0.000135424,0.0001413792],"category_scores_gemma":[0.0006212774,0.0001939216,0.0002545084,0.0001252838,0.0002890208,0.00001746739,0.00006778766,0.0002309731,0.000001543068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003850843,"about_ca_system_score_gemma":0.00005248584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001082335,"about_ca_topic_score_gemma":0.00001948402,"domain_scores_codex":[0.9978586,0.0002787616,0.0008504532,0.0002574031,0.0004863557,0.0002684483],"domain_scores_gemma":[0.9986033,0.0002043583,0.0006160712,0.0001782102,0.0001518062,0.0002462095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8810388,0.0004064045,0.00680345,0.0001018966,0.002782055,0.00006907743,0.002537923,0.0000674615,0.05265882,0.00005755447,0.02614773,0.02732885],"study_design_scores_gemma":[0.9904996,0.00202979,0.001044809,0.0001762793,0.0005943728,0.0005077111,0.000238545,0.0001589965,0.001917708,0.00003634205,0.002612603,0.0001832865],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868079,0.008698201,0.0005761439,0.001745824,0.0009889004,0.0004522432,0.00001171867,0.000008255913,0.000710799],"genre_scores_gemma":[0.9956989,0.0007977476,0.0003389843,0.00005324543,0.002438087,0.0000104326,0.00002274266,0.0000249446,0.0006148646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1094608,"threshold_uncertainty_score":0.7907894,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W993406450","doi":"10.1056/nejmoa1415340","title":"Regional Nodal Irradiation in Early-Stage Breast Cancer","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1296,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Université de Montréal; Hôpital Fleurimont; University of Toronto; McMaster University; Queen's University; BC Cancer Agency; Northeast Cancer Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Canadian Cancer Society Research Institute; Eisai; National Cancer Institute; Cancer Research UK; GlaxoSmithKline; Genomic Health; AstraZeneca; Pfizer; Amgen","keywords":"Breast cancer; NODAL; Irradiation; Stage (stratigraphy); Medicine; Oncology; Internal medicine; Cancer; Biology; Physics","retraction":null,"screen_n_in":null,"score":{"opus":0.02598263655401357,"gpt":0.2916754081126759,"spread":0.2656927715586624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002658913,0.00008845219,0.0001704854,0.00006636554,0.00001436681,0.00000322168,0.00007660284,0.00004430399,0.00002494771],"category_scores_gemma":[0.00005841521,0.00006071214,0.00002811545,0.00007069123,0.0000511544,0.000006107386,0.00001582728,0.00009304736,0.000001141067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005678493,"about_ca_system_score_gemma":0.0002029819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001114159,"about_ca_topic_score_gemma":0.0005947356,"domain_scores_codex":[0.9993264,0.00004076922,0.0002131486,0.00009179586,0.0002148609,0.0001130109],"domain_scores_gemma":[0.9994759,0.00001399175,0.0001491602,0.00007578015,0.0001388834,0.0001462873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003272797,0.0001068884,0.8713503,0.00001325541,0.0002313548,0.0001150256,0.002571026,0.0005981348,0.006648218,0.00007245028,0.0489773,0.06604327],"study_design_scores_gemma":[0.04095284,0.000578094,0.86853,0.0001232584,0.00005223147,0.0006073732,0.0002862021,0.00001023559,0.0003414954,0.0001566293,0.0882541,0.0001075332],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796285,0.003765297,0.0001023458,0.01564806,0.0004537179,0.00004200328,0.000008898801,0.000001974487,0.0003491919],"genre_scores_gemma":[0.9934883,0.000734889,0.0001047832,0.0004065955,0.004976805,0.000001616737,0.000009174271,0.000008125418,0.0002697122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06593573,"threshold_uncertainty_score":0.2475769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2742282063","doi":"10.1093/annonc/mdx308","title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1255,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"National Cancer Institute; Cancer Research UK; American Society for Radiation Oncology","keywords":"Medicine; Breast cancer; Oncology; Radiation therapy; Cancer; Internal medicine; Hormonal therapy; Adjuvant therapy; Stage (stratigraphy); Neoadjuvant therapy; Sentinel node; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.1052867452365607,"gpt":0.3997160847113345,"spread":0.2944293394747738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002169987,0.0001757611,0.0002700692,0.00001992815,0.0003242206,0.00003168916,0.0003437608,0.0001118363,0.00003279189],"category_scores_gemma":[0.00004181253,0.0001073139,0.00009809608,0.00001503706,0.0005030474,0.000008486013,0.0001492742,0.00007542002,2.707838e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003965762,"about_ca_system_score_gemma":0.0002217614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003270217,"about_ca_topic_score_gemma":0.0003622975,"domain_scores_codex":[0.9990582,0.00008450035,0.0002290425,0.0002689742,0.00012021,0.000239035],"domain_scores_gemma":[0.9986444,0.0001594735,0.000493103,0.0003527573,0.0003086076,0.00004163685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004863582,0.0005751636,0.5286719,0.00003123495,0.003250295,0.000006910564,0.00231048,0.00003428642,0.05437003,0.0006500745,0.006011643,0.3992244],"study_design_scores_gemma":[0.001856508,0.0006315205,0.9855482,0.00008326651,0.00003555673,0.00002322789,0.0002406679,0.00006265777,0.008654928,0.0001204931,0.002616083,0.0001269141],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9670009,0.001141526,0.00001290982,0.02800438,0.0001534067,0.000360405,0.001247201,0.000004346516,0.002074944],"genre_scores_gemma":[0.9912811,0.0071667,0.000109577,0.0007594377,0.0002247058,0.0002390349,0.00001558833,0.0000163608,0.0001875099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4568763,"threshold_uncertainty_score":0.4943611,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171015116","doi":"10.1200/jco.2009.24.9284","title":"Breast Cancer Subtypes and the Risk of Local and Regional Relapse","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1242,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Progesterone receptor; Cytokeratin; Oncology; Internal medicine; Tissue microarray; Immunohistochemistry; Estrogen receptor; Cancer; Epidermal growth factor receptor; Proportional hazards model; Lymph node; Basal (medicine); Mastectomy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02651815263737387,"gpt":0.3787242963253215,"spread":0.3522061436879476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001262993,0.00007893658,0.0004632554,0.00001645689,0.00004528732,0.000003173723,0.00009487927,0.0002105842,0.00001319306],"category_scores_gemma":[0.0003895412,0.00004204957,0.0001459,0.00002558877,0.00142069,0.000003748851,0.00008294502,0.0003968275,3.430741e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006373131,"about_ca_system_score_gemma":0.0002909973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000148271,"about_ca_topic_score_gemma":0.0006803799,"domain_scores_codex":[0.9988737,0.0002222443,0.0005990991,0.0001205217,0.00009565124,0.00008885783],"domain_scores_gemma":[0.9981666,0.0006156912,0.0008081039,0.0001101679,0.0002125925,0.00008691063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01367002,0.0004271882,0.6851854,0.00001479964,0.001431358,0.00001833127,0.0001273376,0.00001323791,0.001297948,0.000994703,0.005804163,0.2910155],"study_design_scores_gemma":[0.007144263,0.000810461,0.9655209,0.00001414989,0.0003467533,0.0007786158,0.0001344252,0.00001385191,0.0002779439,0.0008169772,0.02407872,0.00006296283],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869154,0.002994855,0.00008148052,0.009304854,0.0004625159,0.00004528364,0.00001709068,8.202284e-7,0.0001776807],"genre_scores_gemma":[0.9875147,0.01086749,0.0004334398,0.0004717145,0.0006672092,0.000002719591,6.983487e-7,0.00000573436,0.00003624029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2909526,"threshold_uncertainty_score":0.5234591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137935883","doi":"10.1016/s1470-2045(09)70262-1","title":"Ki67 in breast cancer: prognostic and predictive potential","year":2010,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1226,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Oncology; Medicine; Pathological; Oestrogen receptor; Internal medicine; Predictive marker; Cancer; Human Epidermal Growth Factor Receptor 2; Gynecology; Progesterone receptor; Bioinformatics; Estrogen receptor; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0245620792448499,"gpt":0.3433855665218097,"spread":0.3188234872769598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002226047,0.0003235597,0.001160124,0.00004594952,0.00007993283,0.00001290243,0.0003122331,0.0004976837,0.00001723274],"category_scores_gemma":[0.00003321442,0.0002025249,0.0001183822,0.0000983764,0.0003309244,0.000002036776,0.0003211752,0.0004885424,0.000007527861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009238767,"about_ca_system_score_gemma":0.0003894578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001070599,"about_ca_topic_score_gemma":0.0005306008,"domain_scores_codex":[0.9985539,0.0002719316,0.0002597094,0.0004599724,0.0000779903,0.0003765141],"domain_scores_gemma":[0.9992567,0.00007427625,0.0002073897,0.0003697725,0.00004285724,0.00004900612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002013309,0.0001022286,0.001568443,0.001011457,0.0004009609,0.00003228092,0.00006510255,0.000002267104,0.00001993813,0.00003093177,0.002200198,0.9943649],"study_design_scores_gemma":[0.0008286601,0.000134059,0.007032505,0.0006583728,0.0006807293,0.000598687,0.00001881076,0.000002125697,0.000002052575,0.00004156956,0.9897916,0.0002107766],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005975485,0.9954819,0.000006913146,0.001507838,0.0005022531,0.0006725295,0.0007276412,0.00001263204,0.0004907606],"genre_scores_gemma":[0.001971147,0.9945383,0.00005282302,0.0002056713,0.002109757,0.0008310046,0.0001912863,0.00003656733,0.00006345746],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9941541,"threshold_uncertainty_score":0.8258724,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102596641","doi":"10.1158/1078-0432.ccr-07-1658","title":"Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"Breast cancer; Triple-negative breast cancer; Oncology; Progesterone receptor; Internal medicine; Medicine; Cytokeratin; Anthracycline; Tissue microarray; Basal (medicine); Biomarker; Estrogen receptor; Cancer; Proportional hazards model; Pathology; Surrogate endpoint; Immunohistochemistry; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1088655616907161,"gpt":0.4191382268596101,"spread":0.310272665168894,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008299579,0.0003750064,0.000537647,0.00009248918,0.0006999815,0.00005261937,0.0005288535,0.0003397425,0.000328083],"category_scores_gemma":[0.0009431625,0.0002887752,0.0002832598,0.0005522183,0.002224974,0.00001507105,0.0004580745,0.0005503301,0.00007113998],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002514965,"about_ca_system_score_gemma":0.001558963,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008758447,"about_ca_topic_score_gemma":0.001852313,"domain_scores_codex":[0.9958296,0.0007063914,0.0005883815,0.001181165,0.0007106559,0.0009837694],"domain_scores_gemma":[0.9974704,0.0006377487,0.0001283752,0.0006231191,0.0007447423,0.000395597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006416711,0.001168381,0.63628,0.00008557917,0.002009267,0.00006655515,0.0005182787,0.00002053827,0.007977032,0.00001946683,0.3314729,0.01396532],"study_design_scores_gemma":[0.007818987,0.001280431,0.9399307,0.0001925923,0.0001792941,0.00003523274,0.0004444064,0.00008195618,0.009824059,0.0001869746,0.0391794,0.0008459341],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750759,0.009944689,0.00003262978,0.0107007,0.0009005551,0.001107697,0.00168647,0.00004764022,0.0005037364],"genre_scores_gemma":[0.9847789,0.009349249,0.0002270007,0.0006880739,0.000996194,0.001198288,0.0001643243,0.00008495912,0.002513028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3036508,"threshold_uncertainty_score":0.9999564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082326948","doi":"10.1371/journal.pmed.1000279","title":"Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies","year":2010,"lang":"en","type":"review","venue":"PLoS Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1150,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; McGill University; University of British Columbia","funders":"Cancer Council Victoria; National Cancer Institute; KWF Kankerbestrijding; Jewish General Hospital; National Institute for Health and Care Research; Canadian Breast Cancer Research Alliance; Breast Cancer Campaign; Helsingin ja Uudenmaan Sairaanhoitopiiri; NIHR Cambridge Biomedical Research Centre; Sanofi; Mayo Clinic; U.S. Department of Health and Human Services; National Institutes of Health; National Health and Medical Research Council; Cancer Research UK","keywords":"Breast cancer; Immunohistochemistry; Subtyping; Cytokeratin; Oncology; Internal medicine; Hormone receptor; Progesterone receptor; Cancer; Basal (medicine); Biology; Epidermal growth factor receptor; Pathology; Medicine; Estrogen receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.1702420528565186,"gpt":0.4278137955772091,"spread":0.2575717427206904,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002179424,0.0003665847,0.002050116,0.0001288937,0.00007930087,0.000005269249,0.0002394553,0.0002218999,0.000008197761],"category_scores_gemma":[0.0009702028,0.0002800952,0.00007904336,0.0003904676,0.000561808,0.000007886279,0.0003378328,0.0001229077,7.489844e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004278807,"about_ca_system_score_gemma":0.0002036512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004284299,"about_ca_topic_score_gemma":0.0008231049,"domain_scores_codex":[0.9983455,0.00007565001,0.0005932433,0.0006551972,0.0001658838,0.0001645345],"domain_scores_gemma":[0.9976769,0.0007466267,0.0004530172,0.000675707,0.0003404277,0.0001073076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005383928,0.0001841922,0.7695053,0.02229556,0.07053748,0.00001063354,0.001254737,4.241703e-7,0.01086792,0.000005706151,0.003258197,0.1215415],"study_design_scores_gemma":[0.00462266,0.001202247,0.5389453,0.05444624,0.3014099,0.00004922053,0.001754614,0.00000723216,0.003580092,0.00003786072,0.09112415,0.002820547],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1028778,0.8759668,0.00001347767,0.0001729994,0.00004089815,0.0005295199,0.02038809,0.000004895019,0.00000546446],"genre_scores_gemma":[0.05454443,0.9328389,0.0001755197,0.00001874406,0.0002607082,0.0002262136,0.01184308,0.00003844654,0.00005397361],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2308724,"threshold_uncertainty_score":0.9999651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142739119","doi":"10.1093/jnci/dji250","title":"Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Letrozole; Medicine; Hazard ratio; Breast cancer; Tamoxifen; Internal medicine; Interim analysis; Adjuvant therapy; Oncology; Aromatase inhibitor; Placebo; Clinical endpoint; Proportional hazards model; Surgery; Gynecology; Cancer; Randomized controlled trial; Confidence interval; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01683296835497545,"gpt":0.3131470373556251,"spread":0.2963140690006497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005130966,0.0002220452,0.0005853784,0.0001133013,0.0001117627,0.00001978175,0.0003632733,0.0001197984,0.0001133299],"category_scores_gemma":[0.0001734422,0.0001517518,0.0004818279,0.0002128613,0.0001757425,0.00004933887,0.00007912391,0.0002079945,0.000001722091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005043226,"about_ca_system_score_gemma":0.0008954337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001161314,"about_ca_topic_score_gemma":0.0007202562,"domain_scores_codex":[0.9980744,0.0001665401,0.0006702559,0.0002295797,0.0006603107,0.0001989694],"domain_scores_gemma":[0.9986629,0.00007446288,0.0006139011,0.0001253144,0.0004661104,0.0000572366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8623465,0.0006016916,0.005086747,0.000007677231,0.003702861,0.000008230109,0.0007706118,0.004989962,0.1004496,0.0001173343,0.01072993,0.01118885],"study_design_scores_gemma":[0.7994563,0.000232758,0.04208099,0.000384775,0.0003013389,0.00004525794,0.00006079426,0.00004839862,0.1433133,0.0004758319,0.01323851,0.0003617375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883151,0.003756118,0.0000217493,0.004821301,0.001807561,0.0004538116,0.000507907,0.000003791898,0.0003126355],"genre_scores_gemma":[0.9946377,0.002231903,0.0002207615,0.0008845631,0.0016773,0.00008211312,0.00005841679,0.00001797878,0.0001892679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06289017,"threshold_uncertainty_score":0.6188259,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142875113","doi":"10.1016/s1470-2045(07)70278-4","title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","year":2007,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1078,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Saint John Regional Hospital; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Axillary Lymph Node Dissection; Sentinel lymph node; Breast cancer; Surgery; Lymph node; Stage (stratigraphy); Randomized controlled trial; Dissection (medical); Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02027302097998062,"gpt":0.3380045078926205,"spread":0.3177314869126399,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001142725,0.000222284,0.0006181591,0.00003735048,0.0001593836,0.00001127865,0.000208375,0.0002223186,0.00001313545],"category_scores_gemma":[0.0003240648,0.0001263752,0.0001120401,0.0001470199,0.0005049808,0.000009351066,0.0001383173,0.0001868182,9.000216e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001419495,"about_ca_system_score_gemma":0.0001491247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001191094,"about_ca_topic_score_gemma":0.0009507845,"domain_scores_codex":[0.9979548,0.0003776613,0.0006895441,0.0004424267,0.0002241823,0.0003113181],"domain_scores_gemma":[0.9980742,0.0008222028,0.0005014159,0.0003780635,0.0001747347,0.00004934397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5503063,0.0007268611,0.4446199,0.000006158222,0.0003695264,0.000003404815,0.0001403604,0.00003061617,0.0009291175,0.00001943654,0.0002058535,0.002642489],"study_design_scores_gemma":[0.3164681,0.0003096356,0.6822639,0.00002886499,0.0001220179,0.000007616974,0.0001030364,0.00001368623,0.0003967869,0.00006887085,0.0001116953,0.0001059086],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941274,0.0001241258,0.0003312444,0.003447084,0.0003352087,0.0007257243,0.0005162928,0.00001618326,0.0003767685],"genre_scores_gemma":[0.9979325,0.0002984931,0.0002177712,0.0005166775,0.000604265,0.0001336768,0.000249499,0.00001825734,0.0000288546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.237644,"threshold_uncertainty_score":0.5153432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3087393791","doi":"10.1016/s0140-6736(20)31953-x","title":"Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1060,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Atezolizumab; Anthracycline; Oncology; Chemotherapy; Internal medicine; Placebo; Nab-paclitaxel; Breast cancer; Triple-negative breast cancer; Paclitaxel; Stage (stratigraphy); Cancer; Immunotherapy; Pembrolizumab; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02791968987241577,"gpt":0.308306646219802,"spread":0.2803869563473863,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000140581,0.0002758752,0.0004852947,0.000043415,0.00008772021,0.00004348462,0.0001233331,0.00008705463,0.00002013773],"category_scores_gemma":[0.00001661901,0.000171811,0.00003200382,0.00017579,0.0002189747,0.00001917197,0.00003545187,0.00015141,4.496715e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006158081,"about_ca_system_score_gemma":0.0001018023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000658164,"about_ca_topic_score_gemma":0.000604451,"domain_scores_codex":[0.9987631,0.0001140307,0.0002279193,0.0004207639,0.0001904915,0.0002837095],"domain_scores_gemma":[0.9994172,0.00005674354,0.0001737588,0.0002082604,0.00006820568,0.00007582189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9633928,0.0005247805,0.03125653,0.00002443825,0.0002022757,0.000004793508,0.0007112147,0.00004716725,0.0003181912,0.000005627469,0.0001213968,0.003390767],"study_design_scores_gemma":[0.9278846,0.002389396,0.0659354,0.00005969567,0.00004551307,0.000001184377,0.0001073991,0.0001830642,0.002966936,0.000005259445,0.0001930312,0.0002284784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909543,0.0001665263,0.00005228632,0.006404237,0.00006341741,0.002070574,0.000243092,0.00001465742,0.00003094546],"genre_scores_gemma":[0.9981979,0.0003254535,0.00009185965,0.0006053289,0.0002375661,0.0003747692,0.0001205193,0.00003307173,0.00001351081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03550817,"threshold_uncertainty_score":0.700625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234081105","doi":"10.5858/134.7.e48","title":"American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)","year":2010,"lang":"en","type":"review","venue":"Archives of Pathology & Laboratory Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1048,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Breast cancer; Medicine; Guideline; Estrogen receptor; Oncology; Internal medicine; Progesterone receptor; Cancer; Estrogen; Immunohistochemistry; Gynecology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05498342497371125,"gpt":0.4201194376269112,"spread":0.3651360126532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008539794,0.0003620413,0.002984625,0.0001519264,0.00003798119,4.021185e-7,0.0002979104,0.0002793825,0.000005031445],"category_scores_gemma":[0.0008185429,0.0002931183,0.0003012767,0.0004081491,0.006184004,0.000004618393,0.0002532916,0.0003838562,7.87131e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000370866,"about_ca_system_score_gemma":0.001024481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001879409,"about_ca_topic_score_gemma":0.00005421777,"domain_scores_codex":[0.9965196,0.0004899727,0.002021506,0.0005885445,0.0001205266,0.0002598386],"domain_scores_gemma":[0.9950343,0.0009783391,0.003049269,0.0004669745,0.0003829194,0.00008816046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005245162,0.0005658666,0.02659404,0.002306084,0.0005879077,0.000006853864,0.0002843134,4.647675e-7,0.02957366,0.00001569804,0.002149047,0.9373915],"study_design_scores_gemma":[0.008851305,0.0088094,0.03188502,0.01055893,0.003739751,0.0002637242,0.002745081,0.00001381916,0.00402209,0.00005210042,0.9280937,0.0009650875],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1611779,0.8232711,0.0001015241,0.002318573,0.0004812967,0.001444498,0.01115449,0.00001308769,0.00003757806],"genre_scores_gemma":[0.005814523,0.9422126,0.05040818,0.0001297578,0.000270885,0.000268065,0.0008375598,0.00005038828,0.000008041469],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9364265,"threshold_uncertainty_score":0.9999521,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163910197","doi":"10.1093/jnci/djh297","title":"Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1035,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; McGill University; BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Relative risk; Breast cancer; Internal medicine; Randomized controlled trial; Proportional hazards model; Confidence interval; Statistical significance; Chemotherapy; Mastectomy; Survival analysis; Cancer; Surgery; Relative survival; Oncology; Cancer registry","retraction":null,"screen_n_in":null,"score":{"opus":0.00798193284202918,"gpt":0.2431585578857063,"spread":0.2351766250436771,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004806191,0.0001261047,0.0003401838,0.00003176504,0.0002079408,0.00005555784,0.0002905928,0.00007861742,0.00002611153],"category_scores_gemma":[0.0001581811,0.00008842534,0.000206961,0.0001994483,0.0002419567,0.00003503141,0.00004113372,0.0001748414,1.814537e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003398532,"about_ca_system_score_gemma":0.0007210949,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.007432268,"about_ca_topic_score_gemma":0.03823259,"domain_scores_codex":[0.9982925,0.0001663016,0.0005369521,0.0001778729,0.0006863293,0.0001400251],"domain_scores_gemma":[0.998048,0.00004663289,0.001034547,0.0001255315,0.0007127124,0.00003255966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5525132,0.0006165818,0.3613431,0.00001011523,0.001278912,5.976328e-7,0.0002196821,0.01522136,0.0002579859,0.000009265083,0.02169684,0.04683239],"study_design_scores_gemma":[0.3830538,0.00009314217,0.6119553,0.0001439174,0.00005609327,0.000008417564,0.000004747939,0.00001065687,0.0004519576,0.0000614076,0.004067069,0.00009352047],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994112,0.0008176286,0.000007288603,0.002722476,0.0009718054,0.0006180089,0.0006889398,0.000002001133,0.00005980992],"genre_scores_gemma":[0.9953239,0.002337361,0.0001158174,0.0004962642,0.001454139,0.00006588973,0.00002123945,0.00001535651,0.0001700199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2506122,"threshold_uncertainty_score":0.9991773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075213874","doi":"10.1056/nejmoa043681","title":"Adjuvant Docetaxel for Node-Positive Breast Cancer","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":952,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Economics; Sault Area Hospital; Dr. Georges-L.-Dumont University Hospital Centre; Hôpital du Saint-Sacrement; Hôpital Saint-Luc; Nova Scotia Cancer Centre; Saskatchewan Cancer Agency; Ottawa Regional Cancer Foundation","funders":"Association of Medical Research Charities; Canadian Breast Cancer Research Alliance; GlaxoSmithKline; Amgen; Pfizer; Genentech; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Docetaxel; Adjuvant; Breast cancer; Oncology; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.009921351495374873,"gpt":0.2840717143014677,"spread":0.2741503628060928,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001826553,0.0001277191,0.0002601692,0.00004138961,0.00004739134,0.000003849485,0.00009874939,0.00004598685,0.00006109921],"category_scores_gemma":[0.00005249311,0.00008124684,0.00007433216,0.00003984035,0.00006738734,0.000005264534,0.00001947189,0.00007544683,0.000001092757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000388552,"about_ca_system_score_gemma":0.0001166941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008847919,"about_ca_topic_score_gemma":0.000148184,"domain_scores_codex":[0.9993004,0.00002202601,0.0002463761,0.0001199895,0.0001510873,0.000160181],"domain_scores_gemma":[0.9993172,0.00003511157,0.000186523,0.00009216683,0.0002402131,0.0001287972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003909689,0.0001387719,0.01384451,0.00002631547,0.0008941623,0.00002131064,0.0008952732,0.0002917261,0.05110537,0.00006001279,0.09755583,0.831257],"study_design_scores_gemma":[0.1410067,0.002423174,0.1517764,0.0006720122,0.001003591,0.00342656,0.0003993794,0.00005081622,0.03795931,0.0002842709,0.6605521,0.0004456292],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7451313,0.05164341,0.009875147,0.1886955,0.002008806,0.0004483245,0.0003308856,0.00001386781,0.001852738],"genre_scores_gemma":[0.9803736,0.001820069,0.001063235,0.001367666,0.01496804,0.000005885692,0.00001744237,0.0000150868,0.0003689698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8308114,"threshold_uncertainty_score":0.331315,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2230483107","doi":"10.5858/134.6.907","title":"American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":896,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Guideline; Estrogen receptor; Oncology; Internal medicine; Cancer; Progesterone receptor; Immunohistochemistry; Estrogen; Gynecology; Clinical trial; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03289160724815034,"gpt":0.3886922636403727,"spread":0.3558006563922224,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006344374,0.0001716644,0.0009153334,0.0000740891,0.00002735667,2.620538e-7,0.0001685954,0.0001067408,0.000004685199],"category_scores_gemma":[0.000656901,0.000144661,0.00009392229,0.0002434093,0.005576151,0.000004280033,0.0001349463,0.000190892,2.819455e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001202799,"about_ca_system_score_gemma":0.0003660572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002894607,"about_ca_topic_score_gemma":0.0001639016,"domain_scores_codex":[0.9980693,0.0001869579,0.001112997,0.000356356,0.00008134861,0.0001930741],"domain_scores_gemma":[0.9976165,0.0005072243,0.001195558,0.0003020235,0.0003143344,0.00006434585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0004414696,0.000281267,0.3633793,0.00005666586,0.0001138153,0.000001626091,0.0003629132,0.000001137359,0.5956723,0.00002846184,0.0006688413,0.0389922],"study_design_scores_gemma":[0.007121381,0.005613318,0.8447666,0.0003169686,0.0003624937,0.00008630442,0.004524165,0.00006090748,0.1294064,0.0001611214,0.007239721,0.0003405822],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993285,0.0006730703,0.0001257584,0.003986408,0.0001607559,0.0002885884,0.001446866,0.000005089986,0.00002846588],"genre_scores_gemma":[0.9124201,0.0008509508,0.08613621,0.0002134091,0.0001530768,0.00009070642,0.0001133493,0.00001794077,0.000004288336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4813873,"threshold_uncertainty_score":0.9971301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122199930","doi":"10.1016/j.ijrobp.2009.02.031","title":"Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO)","year":2009,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":872,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"American Society for Radiation Oncology","keywords":"Medicine; Breast cancer; Clinical trial; Randomized controlled trial; Medical physics; Task force; Radiation therapy; Statement (logic); Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02496514961749514,"gpt":0.3512100204253304,"spread":0.3262448708078353,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000494293,0.0002584569,0.0004262723,0.00004416324,0.0001852793,0.00004289109,0.0004134785,0.0001869671,0.0000159994],"category_scores_gemma":[0.0001672029,0.0002087671,0.0003897798,0.000131104,0.0002719983,0.00002835252,0.00005200947,0.0002304475,0.000006651846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007396421,"about_ca_system_score_gemma":0.0006678369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007885468,"about_ca_topic_score_gemma":0.00002337302,"domain_scores_codex":[0.9980984,0.0002783616,0.000766415,0.0003379289,0.0002168986,0.000302018],"domain_scores_gemma":[0.9967516,0.0003851062,0.001768981,0.0001853714,0.0008142048,0.0000947033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003158042,0.000855268,0.09594841,0.000002792007,0.003018466,0.000006813347,0.0008453318,0.002679435,0.05080717,0.001581871,0.03821741,0.802879],"study_design_scores_gemma":[0.02055957,0.006219061,0.5270467,0.00003830243,0.0007305245,0.0002072888,0.0009845145,0.004407094,0.01985138,0.006941235,0.4122764,0.0007378718],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9385188,0.001065158,0.02424155,0.03200402,0.00230744,0.0005305251,0.00119731,0.00003248621,0.0001027688],"genre_scores_gemma":[0.9835795,0.001224174,0.004329326,0.004300117,0.005327886,0.00004124322,0.001160685,0.0000244049,0.00001273355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8021411,"threshold_uncertainty_score":0.8513277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966064734","doi":"10.1200/jco.2014.55.7827","title":"Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":842,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Sentinel node; Breast cancer; Biopsy; Axillary Dissection; Chemotherapy; Cancer; Immunohistochemistry; Prospective cohort study; Internal medicine; Oncology; Surgery; Sentinel lymph node","retraction":null,"screen_n_in":null,"score":{"opus":0.0260751244206451,"gpt":0.3866957821892451,"spread":0.3606206577686,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001723093,0.0002518938,0.0009443325,0.00006204182,0.00006744316,0.0000169248,0.0003756714,0.0002926023,0.00004407598],"category_scores_gemma":[0.0002876218,0.0001533909,0.0003753552,0.0001341723,0.0002999714,0.00001001763,0.0001694864,0.0004995882,0.000008869683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009688384,"about_ca_system_score_gemma":0.0004000957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002534178,"about_ca_topic_score_gemma":0.0002459287,"domain_scores_codex":[0.9970399,0.0006627311,0.001352092,0.0003664726,0.0002408335,0.0003379952],"domain_scores_gemma":[0.9978159,0.0003612671,0.001014947,0.0003477295,0.0003185331,0.0001416219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006256575,0.002807858,0.9281371,0.000007404828,0.0009183948,0.0001321353,0.0002947702,0.00003987978,0.002113978,0.000008033493,0.001505729,0.0577782],"study_design_scores_gemma":[0.008081328,0.001324958,0.9816352,0.0000445501,0.000180227,0.0003040217,0.0002965938,0.00003478386,0.0002778396,0.00005395007,0.007594399,0.0001721237],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737259,0.0007423335,0.00009749018,0.02382877,0.0008490854,0.0002320252,0.00003183397,0.000004381428,0.000488167],"genre_scores_gemma":[0.9922174,0.0007529104,0.0003267955,0.004590104,0.001972028,0.00004435911,0.00000396868,0.00002861978,0.00006378317],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05760608,"threshold_uncertainty_score":0.6255099,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161109798","doi":"10.1158/1078-0432.ccr-10-1282","title":"A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":824,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; BC Cancer Agency","keywords":"Breast cancer; Oncology; Immunohistochemistry; Internal medicine; Medicine; Estrogen receptor; Hazard ratio; Progesterone receptor; Tamoxifen; Proportional hazards model; Subtyping; Hormone receptor; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.07446867362571363,"gpt":0.4895050496537869,"spread":0.4150363760280733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009553651,0.0002703776,0.0006731339,0.00007945846,0.0001366035,0.00002636167,0.0003051883,0.0004021098,0.00007737982],"category_scores_gemma":[0.0005695552,0.0002140032,0.0001300736,0.0003550249,0.001731471,0.00001034418,0.0003386289,0.001191575,0.000002686661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009818353,"about_ca_system_score_gemma":0.0006460445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002859514,"about_ca_topic_score_gemma":0.002392602,"domain_scores_codex":[0.9970893,0.0003506158,0.0008193608,0.0008305003,0.0003673026,0.0005428664],"domain_scores_gemma":[0.9978561,0.0006068649,0.0002412403,0.0004647508,0.00059427,0.0002367318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002575222,0.0006135911,0.9529399,0.00005286975,0.0003494731,0.000005351794,0.0001134076,0.000002445638,0.03173231,0.000008856811,0.0002789931,0.01132754],"study_design_scores_gemma":[0.002136542,0.0005767376,0.9609632,0.000225758,0.00007183306,0.000006721594,0.0002378073,0.0000110995,0.03524931,0.000009604872,0.0002801559,0.0002312235],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962038,0.002246396,0.000003441342,0.0004723968,0.0001873605,0.0005328968,0.0002397247,0.00001305877,0.0001008596],"genre_scores_gemma":[0.9974794,0.001583362,0.0001301266,0.00002838676,0.0003731005,0.0002191859,0.00009384598,0.00004099299,0.00005158771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01109632,"threshold_uncertainty_score":0.8726796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106286200","doi":"10.1200/jco.2009.26.3756","title":"American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer","year":2010,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":798,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Adverse effect; Internal medicine; Adjuvant therapy; Guideline; Cancer; Hormone therapy; Clinical trial; Gynecology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1033942419119506,"gpt":0.5353548132279201,"spread":0.4319605713159695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01156823,0.0008797977,0.01100291,0.0001019422,0.0001151454,0.00001615643,0.0009402934,0.002148467,0.00005815637],"category_scores_gemma":[0.004818075,0.0005455349,0.003823616,0.0002738191,0.002265074,0.00002604142,0.0003126845,0.003701881,0.00001055606],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003957243,"about_ca_system_score_gemma":0.01192211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008498683,"about_ca_topic_score_gemma":0.00008910544,"domain_scores_codex":[0.9835103,0.003279822,0.01064249,0.001175437,0.0005986994,0.0007932499],"domain_scores_gemma":[0.965619,0.009288607,0.02044918,0.0007925035,0.003103553,0.0007471363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03608499,0.005459837,0.0005167733,0.0001684813,0.01002266,0.00005724662,0.00002602469,0.000002312101,0.000009333709,0.00001134011,0.07530333,0.8723376],"study_design_scores_gemma":[0.01238776,0.06049409,0.003781042,0.0005996416,0.002495129,0.0005741824,0.0001640802,0.000001627733,0.000006102505,0.00001391838,0.9190003,0.0004821369],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004361953,0.9650766,0.0003288338,0.02097882,0.005001836,0.001948397,0.001564924,0.00001792985,0.0007207576],"genre_scores_gemma":[0.0003847126,0.9478655,0.03050111,0.009259067,0.01130147,0.0002588328,0.0001619101,0.0001376951,0.0001296388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8718555,"threshold_uncertainty_score":0.9996996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095799175","doi":"10.1093/jnci/djr027","title":"Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS","year":2011,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":780,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; AstraZeneca","keywords":"Lumpectomy; Medicine; Randomized controlled trial; Oncology; Internal medicine; Ductal carcinoma; Mastectomy; Breast cancer; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1740238591704341,"gpt":0.4249969340057309,"spread":0.2509730748352968,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002065914,0.0001490508,0.0007501806,0.00007917848,0.00004564366,0.00001165262,0.0002035728,0.00007208923,0.00002344821],"category_scores_gemma":[0.00170248,0.00008563718,0.0004612861,0.00006701455,0.0003632413,0.00002679443,0.00007881808,0.0001135073,2.024863e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005670919,"about_ca_system_score_gemma":0.0004494979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006271359,"about_ca_topic_score_gemma":0.0007400695,"domain_scores_codex":[0.9981558,0.0002871408,0.001009585,0.0001661802,0.0002588401,0.0001224387],"domain_scores_gemma":[0.9980996,0.0003410194,0.0009360095,0.00008216114,0.0004924064,0.0000487926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05307699,0.0002254888,0.9405606,0.00005109301,0.001432769,0.000006803055,0.0002840591,0.00002039371,0.0005312836,0.00007682639,0.0009252815,0.002808421],"study_design_scores_gemma":[0.04433694,0.00009527633,0.9505249,0.000189237,0.0002768745,0.00007631011,0.00001579188,0.00000307273,0.00345425,0.0006846683,0.0002235833,0.000119113],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946398,0.002026828,0.00006841133,0.0007737101,0.001706444,0.0004428783,0.0002631474,0.000001263271,0.0000775158],"genre_scores_gemma":[0.9975885,0.0007581852,0.0005292268,0.0003849514,0.0005632779,0.0001127096,0.000005307361,0.000007388115,0.00005042387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009964288,"threshold_uncertainty_score":0.3492183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4213418594","doi":"10.1093/jnci/djaa201","title":"Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group","year":2020,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":733,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Breast Cancer Research Foundation","keywords":"Breast cancer; Oncology; Medicine; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03829603525344641,"gpt":0.3373352383614399,"spread":0.2990392031079935,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002567078,0.0001756508,0.0002481364,0.00007518806,0.0001003994,0.00003109555,0.000648862,0.00007657786,0.0001981448],"category_scores_gemma":[0.00004201214,0.000119092,0.0001436819,0.0003833777,0.0001213382,0.00004563218,0.0002180092,0.0003228998,5.167486e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007427303,"about_ca_system_score_gemma":0.0009297257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003076188,"about_ca_topic_score_gemma":0.008115578,"domain_scores_codex":[0.9983577,0.00008801149,0.0005750805,0.000233963,0.0005781056,0.0001671015],"domain_scores_gemma":[0.9987556,0.00004518436,0.0005859219,0.0001122277,0.0004458423,0.00005525285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005759359,0.0002143301,0.9309709,0.00001087581,0.0008363494,0.000004578286,0.000355278,0.01948939,0.01797838,0.0003655922,0.02161417,0.007584232],"study_design_scores_gemma":[0.00212856,0.00001629686,0.9653762,0.0003341822,0.00006874325,0.00002921686,0.0001294858,0.0004094239,0.0009481818,0.0001296359,0.03028674,0.0001433247],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7096388,0.002149763,0.0001437811,0.2792066,0.004026554,0.0003122821,0.003964664,0.000006503661,0.0005509836],"genre_scores_gemma":[0.9907854,0.002732804,0.0002857021,0.004226999,0.001783228,0.00006624283,0.00009047698,0.0000147521,0.00001439466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2811466,"threshold_uncertainty_score":0.4856429,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2169649287","doi":"10.1056/nejmoa1412379","title":"Adjuvant Ovarian Suppression in Premenopausal Breast Cancer","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":727,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Tamoxifen; Breast cancer; Medicine; Adjuvant; Oncology; Internal medicine; Estrogen; Ovarian cancer; Antiestrogen; Estrogen receptor; Cancer; Hormone; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.008451759921125611,"gpt":0.2675762164716466,"spread":0.259124456550521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003349709,0.0001118994,0.0002439902,0.00006017658,0.00002442183,0.000003262296,0.0001069328,0.00004886548,0.00009265744],"category_scores_gemma":[0.00008269761,0.00006951979,0.00002534175,0.00005700019,0.00005010375,0.000004401358,0.00003216379,0.0001101221,7.903248e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002580947,"about_ca_system_score_gemma":0.00007896929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003392163,"about_ca_topic_score_gemma":0.0003449802,"domain_scores_codex":[0.9992154,0.00007464422,0.000263026,0.0001172256,0.0001836184,0.0001460349],"domain_scores_gemma":[0.9995075,0.00002477874,0.0001542866,0.0001138584,0.00008626041,0.0001132737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003574989,0.0001604735,0.2374901,0.00003818345,0.0002544376,0.00006191979,0.0009586682,0.0002534252,0.2309143,0.00007372439,0.0318593,0.4943605],"study_design_scores_gemma":[0.07056421,0.001582001,0.7991382,0.0007396768,0.0001604476,0.001137662,0.0001308581,0.00002956444,0.01012124,0.0004004906,0.1157847,0.000210867],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9715285,0.004785634,0.0008902749,0.0202312,0.001214085,0.00009682189,0.00001227518,0.000004554736,0.001236678],"genre_scores_gemma":[0.9935287,0.0007092947,0.0001632851,0.0003281474,0.005139668,0.000001917958,0.000007168062,0.00001041082,0.0001114253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5616481,"threshold_uncertainty_score":0.2834935,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062616726","doi":"10.1016/j.radonc.2014.11.030","title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","year":2015,"lang":"en","type":"article","venue":"Radiotherapy and Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":714,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Cancer Research UK; Health Research Fund of Central Denmark Region; Region Midtjylland; Kræftens Bekæmpelse","keywords":"Guideline; Stage (stratigraphy); Breast cancer; Medicine; Radiation therapy; Consensus conference; Medical physics; Oncology; Cancer; Radiology; Internal medicine; Pathology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02124018233124284,"gpt":0.3312845568332956,"spread":0.3100443745020528,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001722811,0.0001405222,0.0002353355,0.00004205564,0.00005151235,0.000005201613,0.00005108081,0.0001387367,0.00001593551],"category_scores_gemma":[0.00002375199,0.0001212612,0.00005114579,0.00005197503,0.00009790147,0.000003327026,0.000007703975,0.0000403799,3.6107e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001811255,"about_ca_system_score_gemma":0.0002550625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003756492,"about_ca_topic_score_gemma":0.0001115266,"domain_scores_codex":[0.9992254,0.00007534009,0.0002169701,0.0002496451,0.00006979852,0.0001627813],"domain_scores_gemma":[0.9993659,0.00003514926,0.0001590048,0.0001199881,0.0002606669,0.00005925495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03284289,0.0009309307,0.2436034,0.00002757156,0.001805274,0.000004832824,0.002108156,0.003683528,0.120667,0.0006092691,0.04192847,0.5517886],"study_design_scores_gemma":[0.02242357,0.01205485,0.145395,0.00001689334,0.00006380876,0.00005142883,0.0003148797,0.003057986,0.05513081,0.0002553657,0.7607164,0.0005190097],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977143,0.008612438,0.009724401,0.003115977,0.0002639581,0.000551047,0.0004703764,0.00001386834,0.000104962],"genre_scores_gemma":[0.9859828,0.004702044,0.006480687,0.00127865,0.000777864,0.0001926152,0.0001702199,0.00003284877,0.0003822357],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7187879,"threshold_uncertainty_score":0.4944888,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2806866264","doi":"10.1056/nejmoa1803164","title":"Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":673,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Breast Cancer Research Foundation; Pfizer; Oncosuisse; Ipsen Fund; Ipsen; National Institute for Health and Care Research","keywords":"Exemestane; Tamoxifen; Medicine; Breast cancer; Oncology; Aromatase inhibitor; Internal medicine; Aromatase; Endocrine system; Adjuvant; Gynecology; Adjuvant therapy; Cancer; Hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.0205600520217908,"gpt":0.3093109141611659,"spread":0.2887508621393751,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001969147,0.0001315451,0.0002412781,0.00004366458,0.00006179215,0.00000447643,0.0001168497,0.00002863385,0.0001042767],"category_scores_gemma":[0.00005126453,0.00008115258,0.00004431442,0.00004713653,0.0001068785,0.000004909978,0.00002290197,0.0000609643,7.448434e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002431282,"about_ca_system_score_gemma":0.0001122219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001557326,"about_ca_topic_score_gemma":0.0001147355,"domain_scores_codex":[0.9992599,0.00002259889,0.0002436448,0.0001299355,0.0001596837,0.0001842527],"domain_scores_gemma":[0.9992555,0.00002564167,0.00017812,0.0001140855,0.0003132792,0.0001133273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007829587,0.000107585,0.03586497,0.00002258409,0.0008538283,0.00002011285,0.0005578018,0.00001271822,0.3088146,0.00005237869,0.0423796,0.6034843],"study_design_scores_gemma":[0.1132134,0.008602248,0.1082009,0.0003440966,0.0002808422,0.001697411,0.0001626455,0.000008163011,0.1071067,0.0003884239,0.6597071,0.0002881066],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678191,0.01191704,0.001884717,0.01589581,0.001818653,0.0002217434,0.00003867796,0.000007456284,0.0003968224],"genre_scores_gemma":[0.9732015,0.002427595,0.0004324056,0.0004722561,0.0232148,0.000008511153,0.000007549557,0.00001723415,0.0002181909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6173275,"threshold_uncertainty_score":0.3309306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143899676","doi":"10.1093/jnci/94.15.1143","title":"Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer","year":2002,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":665,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Cancer Care Ontario","funders":"","keywords":"Lumpectomy; Medicine; Breast cancer; Radiation therapy; Mastectomy; Confidence interval; Dose fractionation; Randomized controlled trial; Surgery; Oncology; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01796132193505025,"gpt":0.2804399152882907,"spread":0.2624785933532404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003001506,0.0001787464,0.000400375,0.00007691515,0.0001077156,0.00001792603,0.0002022267,0.00007360914,0.00007350913],"category_scores_gemma":[0.0001251089,0.0001078838,0.0002230344,0.0001493483,0.0002954626,0.00003788531,0.00003872592,0.00007921007,5.424876e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004271059,"about_ca_system_score_gemma":0.0004625854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001119434,"about_ca_topic_score_gemma":0.0001329792,"domain_scores_codex":[0.998669,0.00007540168,0.0004186016,0.0001686604,0.0004918498,0.0001764557],"domain_scores_gemma":[0.9979668,0.00006074077,0.0006942769,0.0001016344,0.001119222,0.00005730582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9798518,0.000380085,0.004794091,0.00007268537,0.002921644,0.000001470693,0.0005072479,0.004746686,0.001967665,0.0002337682,0.001102695,0.003420186],"study_design_scores_gemma":[0.8799893,0.0001955535,0.1117554,0.0002741113,0.0004378715,0.0001783912,0.00007978822,0.0001947775,0.003563069,0.0007278442,0.002291547,0.0003123882],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907635,0.001216379,0.0002388698,0.004360507,0.001215804,0.000693347,0.001225817,0.000003819282,0.0002819728],"genre_scores_gemma":[0.9959868,0.0005353582,0.000504837,0.0003788087,0.001791727,0.000608448,0.000005369719,0.00001684348,0.000171865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1069613,"threshold_uncertainty_score":0.4399372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106193652","doi":"10.1001/jama.290.4.465","title":"Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease","year":2003,"lang":"en","type":"article","venue":"JAMA","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":659,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cancer Care Ontario; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Radiation therapy; Cancer; Internal medicine; Relative risk; Chemotherapy; Population; Oncology; Confidence interval; Cohort; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.003528871967852651,"gpt":0.2253577241768544,"spread":0.2218288522090018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006602905,0.0001752699,0.0001456043,0.00002082899,0.0001030832,0.0000388116,0.00005892828,0.00005411201,0.00004327593],"category_scores_gemma":[0.000007619837,0.0001371508,0.00003894613,0.00006868142,0.00008681504,0.000008146407,0.00001446114,0.00004346266,5.298548e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008089579,"about_ca_system_score_gemma":0.00007348473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001400628,"about_ca_topic_score_gemma":0.000092838,"domain_scores_codex":[0.9992069,0.00003484042,0.00007847268,0.0003198074,0.0001001662,0.0002597952],"domain_scores_gemma":[0.9995639,0.000006137863,0.00004136955,0.0002024018,0.00002726259,0.0001589644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008051047,0.00006710811,0.9788251,0.00001511829,0.0005324736,0.00001814796,0.0005123215,0.00001396112,0.003506277,0.00002668486,0.00086289,0.0148148],"study_design_scores_gemma":[0.003981035,0.00007567562,0.9866326,0.00002655825,0.00003434118,0.00003664258,0.0002105242,0.000004833341,0.001579793,0.00002924678,0.007146219,0.0002424583],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951901,0.003131699,0.0001789112,0.0009015193,0.00007395836,0.0001523463,0.00003838799,0.00001669248,0.0003163946],"genre_scores_gemma":[0.9971119,0.001057887,0.0003087145,0.0007968576,0.0001702458,0.0001771507,0.000008582848,0.00003518335,0.0003334584],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01457234,"threshold_uncertainty_score":0.5592849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2043468165","doi":"10.1056/nejmoa040595","title":"Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer","year":2004,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":656,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Hazard ratio; Lumpectomy; Radiation therapy; Oncology; Internal medicine; Confidence interval; Gynecology; Cancer; Mastectomy","retraction":null,"screen_n_in":null,"score":{"opus":0.007441468886969171,"gpt":0.2510189149949371,"spread":0.2435774461079679,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001642858,0.0001427144,0.0003628592,0.00009140646,0.00001785273,0.000004931046,0.00009846587,0.00005144696,0.00005698708],"category_scores_gemma":[0.00001611109,0.000073587,0.00001967288,0.0001583346,0.0001236296,0.00001161273,0.00001480933,0.0001107296,3.094883e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009352633,"about_ca_system_score_gemma":0.000385823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001760494,"about_ca_topic_score_gemma":0.002934062,"domain_scores_codex":[0.9991153,0.00003016084,0.0002604907,0.0001391185,0.000269091,0.0001858203],"domain_scores_gemma":[0.9993615,0.00001474174,0.0002564345,0.0001211745,0.0001189252,0.0001272384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07504702,0.0005148426,0.7131131,0.0001293514,0.001488831,0.0009271567,0.01721539,0.001287795,0.01717048,0.0000131825,0.001020596,0.1720723],"study_design_scores_gemma":[0.05615669,0.002488099,0.9358836,0.0007547735,0.0001010946,0.00239941,0.0005059844,5.290296e-7,0.0003765548,0.00002093132,0.001193058,0.0001192204],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962717,0.000639236,0.0001199878,0.002725318,0.00007023181,0.0001093427,0.00001873108,0.000002570566,0.00004288244],"genre_scores_gemma":[0.9974306,0.000613375,0.0004230634,0.0001940713,0.001126153,0.000007721904,0.000004869309,0.00001964378,0.0001805117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2227706,"threshold_uncertainty_score":0.3000791,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901314939","doi":"10.1200/jco.18.01160","title":"Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":630,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Guideline; Tolerability; Oncology; Internal medicine; Adjuvant therapy; Cancer; Aromatase inhibitor; Adjuvant; Clinical trial; Gynecology; Randomized controlled trial; Aromatase; Adverse effect; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04558983545075149,"gpt":0.4509187382371283,"spread":0.4053289027863768,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003349066,0.0002829088,0.00134257,0.00003982964,0.0001398848,0.00001602258,0.0003420599,0.0003462549,0.00007263617],"category_scores_gemma":[0.001832324,0.0001848489,0.0003644724,0.0001087931,0.0007521613,0.00002792218,0.0001194504,0.0004479875,0.00001101542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001542475,"about_ca_system_score_gemma":0.001651225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006089177,"about_ca_topic_score_gemma":0.00009963688,"domain_scores_codex":[0.9956715,0.0006001514,0.002498968,0.0004700901,0.0002922808,0.000467046],"domain_scores_gemma":[0.9928729,0.001069413,0.002631086,0.0003232038,0.002739257,0.000364146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1388996,0.002893533,0.01149986,0.000005390828,0.004303053,0.00006925529,0.00008436433,0.000006423126,0.00155136,0.00003453518,0.1181138,0.7225388],"study_design_scores_gemma":[0.02036569,0.04197117,0.1017332,0.00002753513,0.0002746544,0.0004084086,0.0001751769,0.000006639279,0.0008609142,0.00008429019,0.8338637,0.0002285342],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8946723,0.00697393,0.003712516,0.08872784,0.003091793,0.0008245669,0.0004493876,0.00001991342,0.001527719],"genre_scores_gemma":[0.8626345,0.0438328,0.05537627,0.01996973,0.01768398,0.0001287675,0.00005055992,0.0000859363,0.0002374096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7223103,"threshold_uncertainty_score":0.7537918,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067428007","doi":"10.1001/jama.2014.17322","title":"Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States","year":2015,"lang":"en","type":"article","venue":"JAMA","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":615,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Women's College Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Hazard ratio; Cancer; Internal medicine; Epidemiology; Ethnic group; Surveillance, Epidemiology, and End Results; Odds ratio; Gynecology; Cancer registry; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.03315162281593784,"gpt":0.2860214853343843,"spread":0.2528698625184465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001514634,0.0001347546,0.0001580515,0.00003012547,0.00004881759,0.00002909816,0.00008978025,0.00007052181,0.00001240266],"category_scores_gemma":[0.00001567689,0.00009180167,0.00001230548,0.0001330036,0.0001403105,0.000005657719,0.0001218632,0.00007935148,3.960315e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006663172,"about_ca_system_score_gemma":0.00002443417,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01768026,"about_ca_topic_score_gemma":0.02012631,"domain_scores_codex":[0.9992117,0.0001302117,0.000108045,0.0002609716,0.0001078036,0.0001813041],"domain_scores_gemma":[0.9996838,0.00006460318,0.00003463193,0.0001236623,0.00004335048,0.00004994641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002047176,0.00006295881,0.9861628,0.00001146808,0.00003111808,0.000003969158,0.00139401,0.00001172827,0.0006648503,0.000006743074,0.007025306,0.004420262],"study_design_scores_gemma":[0.001631362,0.0000420798,0.9737744,0.00002675902,0.000009796693,0.000003156055,0.001647781,0.0000232906,0.001669496,0.00001214794,0.02102934,0.0001303662],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.974396,0.01722453,0.00000198223,0.007549675,0.00005716009,0.0001297381,0.0006011143,0.000003944886,0.00003586521],"genre_scores_gemma":[0.9514751,0.04774126,0.000005121101,0.0003505283,0.00006411204,0.0001871447,0.00008458748,0.000008311133,0.00008384628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03051673,"threshold_uncertainty_score":0.9977539,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2789698864","doi":"10.1016/j.prro.2018.01.012","title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","year":2018,"lang":"en","type":"article","venue":"Practical Radiation Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":606,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Guideline; Breast cancer; Medical physics; Grading (engineering); Radiation therapy; Dose fractionation; Radiation oncology; Medical prescription; Radiation treatment planning; Oncology; Cancer; Internal medicine; Pathology; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.04448821864523543,"gpt":0.4146652460524682,"spread":0.3701770274072327,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001051989,0.0002189345,0.0003657401,0.00005195581,0.0002916927,0.00001802114,0.0001815578,0.0002420822,0.00001998796],"category_scores_gemma":[0.001199784,0.0001746496,0.0002682461,0.000186953,0.0005877739,0.00005140609,0.00003795302,0.0001082035,0.000003471033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000367929,"about_ca_system_score_gemma":0.00115065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001491117,"about_ca_topic_score_gemma":0.0001205369,"domain_scores_codex":[0.9981379,0.0003322758,0.0005158539,0.0004926744,0.0001720347,0.0003492921],"domain_scores_gemma":[0.9960791,0.002073525,0.0007456004,0.0003458197,0.0006550468,0.0001008682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007571852,0.0008007539,0.002102875,0.00001561229,0.0006095078,4.96693e-7,0.0004008696,0.000255494,0.02881406,0.0003132743,0.08359251,0.8755227],"study_design_scores_gemma":[0.006176604,0.01061387,0.02296923,0.00001140119,0.0003255853,0.00002320349,0.0006299186,0.01472554,0.03319782,0.0001740496,0.9108892,0.0002635929],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.1552363,0.009842884,0.5473096,0.2741801,0.002540173,0.008205833,0.001934813,0.0001354709,0.0006147755],"genre_scores_gemma":[0.9310885,0.003878106,0.04648515,0.01076962,0.004066418,0.001768056,0.001768521,0.00006894505,0.0001066968],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8752591,"threshold_uncertainty_score":0.7122005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144535237","doi":"10.1093/jnci/djt306","title":"An International Ki67 Reproducibility Study","year":2013,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":598,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta; University of British Columbia","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Reproducibility; Concordance; Medicine; Breast cancer; Oncology; Consistency (knowledge bases); Medical physics; Cancer; Pathology; Internal medicine; Statistics; Computer science; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.03862535258212422,"gpt":0.359667195747888,"spread":0.3210418431657637,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004536679,0.00009939331,0.0001107899,0.00003973507,0.0001106683,0.00003482724,0.0004813334,0.00003549301,0.00007158053],"category_scores_gemma":[0.0003934234,0.00006434829,0.0001000463,0.00008503632,0.00008809152,0.00005232115,0.0001015835,0.0001049306,0.00000465571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001748814,"about_ca_system_score_gemma":0.0002904064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001966776,"about_ca_topic_score_gemma":0.0001948126,"domain_scores_codex":[0.9987834,0.00005831372,0.0002873208,0.0002773637,0.0005011847,0.00009238232],"domain_scores_gemma":[0.9982738,0.000007848584,0.0002614997,0.0003218025,0.001087797,0.00004720474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003771546,0.001437732,0.9016352,0.000008062692,0.001235672,0.000003502001,0.0005648261,0.005730491,0.05305303,0.0001836215,0.02579394,0.009976762],"study_design_scores_gemma":[0.001067633,0.0001598044,0.9629315,0.00001425191,0.00004404716,0.00005015734,0.0001083513,0.00001811276,0.009756492,0.0004735338,0.02527253,0.0001036116],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993277,0.0001787306,0.00002921436,0.002822802,0.002837028,0.0001967181,0.00003972736,0.000003369082,0.000615458],"genre_scores_gemma":[0.9965629,0.0000555863,0.0002380024,0.0006461334,0.002313877,0.0000361783,0.00000731958,0.000007282932,0.0001327249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06129626,"threshold_uncertainty_score":0.2624047,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097977223","doi":"10.1200/jco.2005.06.178","title":"Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":572,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; Canadian Breast Cancer Research Alliance","keywords":"Medicine; Breast cancer; Internal medicine; Adjuvant; Oncology; Lymphovascular invasion; Population; Adjuvant therapy; Cancer; Gynecology; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.06635707897107647,"gpt":0.4282446016400686,"spread":0.3618875226689922,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005336911,0.0000828529,0.0004089996,0.00002084455,0.00004204042,0.000003110158,0.0001527931,0.0001693276,0.000008240915],"category_scores_gemma":[0.0006171004,0.00005174253,0.0003248705,0.00004258722,0.00007791176,0.0000061479,0.00003042402,0.0001143105,4.289416e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005187963,"about_ca_system_score_gemma":0.00070367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003062497,"about_ca_topic_score_gemma":0.0001196297,"domain_scores_codex":[0.9986635,0.0001152114,0.0008562156,0.0001160813,0.0001382511,0.0001107289],"domain_scores_gemma":[0.9980239,0.0002852208,0.001081149,0.000126603,0.0004287087,0.00005444054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001724456,0.0005624452,0.9274242,0.00001467942,0.0002577999,4.276763e-7,0.00002262078,0.02241627,0.0009268015,0.00003785818,0.0009716481,0.04564079],"study_design_scores_gemma":[0.00359425,0.0008203983,0.9897778,0.00003663442,0.0002709447,0.000008444319,0.000008518141,0.001417811,0.002259788,0.0001924245,0.001546107,0.00006690131],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894126,0.0002735816,0.001647612,0.007917738,0.0004466946,0.0001723288,0.00006507743,0.000001618222,0.00006271983],"genre_scores_gemma":[0.9956011,0.0000679225,0.002724204,0.0005679964,0.0009557137,0.00001785125,0.000007099067,0.00001009054,0.00004799998],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06235357,"threshold_uncertainty_score":0.2109999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106833357","doi":"10.1186/s12920-015-0129-6","title":"Development and verification of the PAM50-based Prosigna breast cancer gene signature assay","year":2015,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":560,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Oncology; Breast cancer; Medicine; Internal medicine; Bioinformatics; Cancer; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01976869890294278,"gpt":0.2510871811424888,"spread":0.2313184822395461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023665,0.0001025084,0.0001081252,0.00001017031,0.00004744556,0.00000495428,0.0001397037,0.0001302807,0.000008128815],"category_scores_gemma":[0.00008499588,0.00006876073,0.00002973834,0.00004795046,0.0001289299,0.000001210518,0.00009695813,0.00005885959,0.000001108469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006023781,"about_ca_system_score_gemma":0.001257165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002604608,"about_ca_topic_score_gemma":0.0001977495,"domain_scores_codex":[0.999256,0.00005346327,0.0001519653,0.0001997927,0.0002193077,0.0001194685],"domain_scores_gemma":[0.9995188,0.00001675549,0.00008077487,0.0001880761,0.00008462839,0.0001109965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001669872,0.0008377642,0.3764382,0.0004162729,0.0006928034,0.000005389637,0.002320494,0.0009509873,0.4724379,0.0002757552,0.008632113,0.1353225],"study_design_scores_gemma":[0.003727597,0.00007048556,0.3531412,0.0001147261,0.0001113108,0.00003869081,0.0003026736,0.0006941888,0.6003686,0.0000455244,0.04097384,0.0004111616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928985,0.002800558,0.002858382,0.0008490067,0.0002088981,0.0002257688,0.00006611201,0.000007325416,0.00008551322],"genre_scores_gemma":[0.99371,0.0001098128,0.005457645,0.0003801714,0.0001686767,0.00006613263,0.00004728064,0.0000131915,0.00004704649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1349113,"threshold_uncertainty_score":0.2803981,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013600972","doi":"10.1056/nejmoa0810266","title":"Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":559,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Cancer Society","funders":"National Cancer Institute","keywords":"Medicine; Capecitabine; Breast cancer; Oncology; Chemotherapy; Adjuvant chemotherapy; Stage (stratigraphy); Adjuvant; Internal medicine; Cancer; Clinical trial; Gynecology; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.005481734950213392,"gpt":0.2537018345176501,"spread":0.2482200995674367,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001703123,0.0001326812,0.0002741312,0.00006194897,0.00001959482,0.000004112174,0.0000935666,0.00004171444,0.0001204465],"category_scores_gemma":[0.000009977321,0.00007719587,0.00002124608,0.00008904564,0.00005286715,0.00000530821,0.000007332437,0.0001113361,3.981572e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005436122,"about_ca_system_score_gemma":0.0001059401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002016961,"about_ca_topic_score_gemma":0.0001463563,"domain_scores_codex":[0.9992711,0.00002517411,0.0002077769,0.0001202843,0.0001820548,0.000193588],"domain_scores_gemma":[0.9995328,0.000009251099,0.000144226,0.0001066978,0.00008080431,0.0001261983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01107845,0.000302858,0.3301985,0.00001994954,0.0004422574,0.0002672354,0.006096566,0.0001583061,0.03216157,0.00001674726,0.006457321,0.6128003],"study_design_scores_gemma":[0.04716004,0.001636578,0.9354709,0.0001926128,0.00002687365,0.0003854931,0.0002515404,9.564574e-7,0.001437084,0.00004390881,0.01328963,0.0001044159],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840339,0.002443793,0.00009921885,0.01300646,0.00009944721,0.0000624349,0.000005613837,0.000002470825,0.000246613],"genre_scores_gemma":[0.9944716,0.001769966,0.0000956417,0.001274874,0.002062417,0.000002441987,0.0000022206,0.00001047747,0.0003103699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6126959,"threshold_uncertainty_score":0.3147956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2110578052","doi":"10.1002/path.2407","title":"Refinement of breast cancer classification by molecular characterization of histological special types","year":2008,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":558,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Breast cancer; Characterization (materials science); Computational biology; Pathology; Biology; Cancer; Medicine; Internal medicine; Materials science; Nanotechnology","retraction":null,"screen_n_in":null,"score":{"opus":0.01527521027363537,"gpt":0.2516024986796402,"spread":0.2363272884060049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001239308,0.00007003283,0.0001773354,0.00002564312,0.00003086107,5.395331e-7,0.0001155804,0.000063003,0.00003860703],"category_scores_gemma":[0.00001907407,0.00004544171,0.00005563766,0.00004599312,0.0002057785,0.000002446373,0.00003188828,0.000051032,5.819824e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002177311,"about_ca_system_score_gemma":0.00005162098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008736258,"about_ca_topic_score_gemma":0.00000384088,"domain_scores_codex":[0.9993755,0.0001071924,0.0002751587,0.00006882901,0.00009790879,0.00007543285],"domain_scores_gemma":[0.9991962,0.000008767794,0.0004734707,0.0001155465,0.0001890375,0.00001692609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0003728835,0.0001084091,0.007852338,0.000005467868,0.00007561759,0.000008945876,0.0001375821,0.000007023267,0.9892889,0.00004506745,0.0007302223,0.001367501],"study_design_scores_gemma":[0.0007964388,0.0004285894,0.6083432,0.00001615162,0.000142488,0.001113636,0.00006040342,0.00000297746,0.3866303,0.00003744348,0.002350793,0.00007757675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969302,0.0009155043,0.0006665544,0.001100384,0.0001491731,0.00004497664,0.00006590421,9.158942e-7,0.0001264316],"genre_scores_gemma":[0.9975787,0.001947038,0.00008803993,0.00008374275,0.000237595,0.000002675442,0.00002035595,0.000005428991,0.00003638075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6026587,"threshold_uncertainty_score":0.1853059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2948923376","doi":"10.1056/nejmoa1904819","title":"Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":555,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Sunnybrook Hospital","funders":"National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Adjuvant chemotherapy; Chemotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03262880315139176,"gpt":0.3362689219197941,"spread":0.3036401187684023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000431546,0.00008438084,0.0002670985,0.00002250424,0.00002454127,0.000003115186,0.00008868948,0.00003584677,0.00002336625],"category_scores_gemma":[0.0001084163,0.00004086136,0.00006137085,0.00002637384,0.00008152606,0.000002700383,0.0000276229,0.00006852322,3.240696e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008164844,"about_ca_system_score_gemma":0.0000911868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003478339,"about_ca_topic_score_gemma":0.0001298307,"domain_scores_codex":[0.9993289,0.00005653414,0.0003255455,0.0001041151,0.00009444842,0.0000904655],"domain_scores_gemma":[0.9992582,0.0001402638,0.0002324879,0.0001355979,0.0001500795,0.00008333041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002735998,0.00002829397,0.4960603,0.000006899076,0.0004093925,0.000001183035,0.0002787507,0.00008368366,0.01371909,0.000005348903,0.01877842,0.4678927],"study_design_scores_gemma":[0.02282835,0.001417298,0.6933634,0.00007757104,0.0001230528,0.0001169411,0.00007384289,0.000007658765,0.0007011218,0.00003500774,0.2812002,0.00005563337],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848425,0.006283385,0.0003502101,0.007880885,0.0003980335,0.0001755269,0.0000538782,7.703648e-7,0.00001482875],"genre_scores_gemma":[0.9752508,0.01981935,0.0007005077,0.001093379,0.002916928,0.000003130184,0.000002329777,0.00001076769,0.0002028163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.467837,"threshold_uncertainty_score":0.1666278,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098753081","doi":"10.1200/jco.2005.03.2235","title":"Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":543,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Regional Cancer Foundation; Cancer Care Ontario","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Survivorship curve; Quality of life (healthcare); Cancer; Clinical trial; Stage (stratigraphy); Internal medicine; Hormonal therapy; Pediatrics","retraction":null,"screen_n_in":null,"score":{"opus":0.09056362573536841,"gpt":0.4567536643190786,"spread":0.3661900385837102,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000773594,0.0001891941,0.002379026,0.00005236487,0.00004417841,0.000005721037,0.0002408314,0.0003129831,0.000007296092],"category_scores_gemma":[0.0003725921,0.0001450741,0.00135966,0.00006743315,0.0004725525,0.000007310378,0.00006747342,0.0001898751,4.658413e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008014643,"about_ca_system_score_gemma":0.0007341913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003407199,"about_ca_topic_score_gemma":0.0006898838,"domain_scores_codex":[0.9967277,0.0003641071,0.002232772,0.0002190853,0.0002444596,0.0002118913],"domain_scores_gemma":[0.9949995,0.0009036954,0.003056261,0.0001965095,0.0007610219,0.0000829803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9406382,0.001246946,0.02368309,0.00005143361,0.001338356,0.000007476472,0.00008961371,0.00003939305,0.0009613514,0.00005826012,0.001286924,0.03059891],"study_design_scores_gemma":[0.8924003,0.007259168,0.09263878,0.00005700762,0.001050381,0.00000260477,0.0001920762,0.000003673212,0.002881539,0.00003181287,0.003345958,0.0001366944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918098,0.002093648,0.0002238132,0.0003873472,0.003558505,0.0005486934,0.0002383108,0.000002436831,0.001137436],"genre_scores_gemma":[0.9948588,0.0005301867,0.0003836244,0.0001003291,0.003953002,0.00003388639,0.00003604281,0.00001938075,0.00008473626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0689557,"threshold_uncertainty_score":0.591595,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}